Download FREE Report Sample
Download Free sampleLatanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Latanoprost Market contains market size and forecasts of Latanoprost in global, including the following market information:
Global Latanoprost Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Latanoprost Market Sales, 2017-2022, 2023-2028, (M Unit)
Global top five Latanoprost companies in 2021 (%)
The global Latanoprost market was valued at 1413.9 million in 2021 and is projected to reach US$ 1635.9 million by 2028, at a CAGR of 2.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Brand Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Latanoprost include Pfizer, Mylan, Novartis, Apotex, Teva, Taj Pharma and CR Zizhu, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Latanoprost manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Latanoprost Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Latanoprost Market Segment Percentages, by Type, 2021 (%)
Brand Drug
Generic Drug
Global Latanoprost Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Latanoprost Market Segment Percentages, by Application, 2021 (%)
Open-angle Glaucoma
Close-angle Glaucoma
Global Latanoprost Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Latanoprost Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Latanoprost revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Latanoprost revenues share in global market, 2021 (%)
Key companies Latanoprost sales in global market, 2017-2022 (Estimated), (M Unit)
Key companies Latanoprost sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy